HUB Organoids BV
HUB Organoids BV is a pioneering biotechnology company specializing in the application of Organoid Technology to drug discovery, personalized medicine, and disease modeling. Founded in 2013 following the discovery of adult stem cells, HUB´s drug development platform uses advanced 3D organoid models derived from patient tissues, enabling more
accurate and predictive research for preclinical testing and therapeutic development. HUB´s innovative platform accelerates the discovery of effective treatments by closely mimicking human biology and is available on a fee for service basis to scientists working in drug discovery and development in the therapeutic areas of oncology, inflammation/IBD, infectious
diseases, and for toxicology investigation.
HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany.
